|
NEIL3 expression based on
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.622800E-01 |
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.774200E-01 |
| Normal-vs-Stage2 |
8.098600E-01 |
| Normal-vs-Stage3 |
6.875400E-01 |
| Normal-vs-Stage4 |
5.416200E-01 |
| Stage1-vs-Stage2 |
7.467600E-01 |
| Stage1-vs-Stage3 |
3.494000E-01 |
| Stage1-vs-Stage4 |
2.941800E-01 |
| Stage2-vs-Stage3 |
9.639800E-01 |
| Stage2-vs-Stage4 |
4.278000E-01 |
| Stage3-vs-Stage4 |
1.243200E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.576000E-01 |
| Normal-vs-AfricanAmerican |
8.697400E-01 |
| Normal-vs-Asian |
4.911000E-01 |
| Caucasian-vs-AfricanAmerican |
7.689200E-01 |
| Caucasian-vs-Asian |
4.212600E-01 |
| AfricanAmerican-vs-Asian |
3.958000E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.115400E-01 |
| Normal-vs-Female |
9.147800E-01 |
| Male-vs-Female |
6.516400E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.286600E-01 |
| Normal-vs-Age(41-60Yrs) |
4.821800E-01 |
| Normal-vs-Age(61-80Yrs) |
9.274400E-01 |
| Normal-vs-Age(81-100Yrs) |
1.983010E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.923500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.475200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.220600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.845570E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.088600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.104400E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.262800E-01 |
| Classical-VS-Follicular |
6.009000E-04 |
| Classical-VS-Other |
1.047980E-01 |
| Classical-VS-Normal |
7.378400E-01 |
| Tall-VS-Follicular |
5.656300E-02 |
| Tall-VS-Other |
3.768200E-01 |
| Tall-VS-Normal |
9.313000E-01 |
| Follicular-VS-Other |
8.400800E-01 |
| Follicular-VS-Normal |
2.077200E-01 |
| Other-VS-Normal |
3.874800E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.716200E-01 |
| Normal-vs-N1 |
8.311800E-01 |
| N0-vs-N1 |
7.480800E-01 |
|
|
